Zoetis Wins EU Authorization for Poulvac Procerta HVT-ND Poultry Vaccine
Zoetis Inc. (NYSE: ZTS) announced that the European Commission has granted marketing authorization for Poulvac Procerta HVT-ND, a recombinant vector vaccine for protecting chickens against Newcastle disease and Marek's disease viruses. The vaccine can be administered either in ovo or by subcutaneous injection at hatch, providing protection against both diseases in a single dose.